Treatment Of Hepatic Encephalopathy With The Benzodiazepine Antagonist Flumazenil
- 1 January 1989
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- REVERSAL OF HEPATIC COMA WITH FLUMAZENIL WITH IMPROVEMENT IN VISUAL EVOKED POTENTIALSThe Lancet, 1988
- Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathyJournal of Neuroscience, 1988
- Portal-systemic encephalopathy: alterations in somatosensory and brainstem auditory evoked potentialsJournal of the Neurological Sciences, 1988
- Ro 15-1788 and Hepatic FailureAnnals of Internal Medicine, 1988
- Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failureGastroenterology, 1987
- REVERSAL OF HEPATIC COMA BY BENZODIAZEPINE ANTAGONIST (Ro 15-1788)The Lancet, 1985
- Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine AntagonistClinical Science, 1984
- Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the ratBrain Research, 1984
- HEPATIC ENCEPHALOPATHY AND THE γ-AMINOBUTYRIC-ACID NEUROTRANSMITTER SYSTEMThe Lancet, 1982
- ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESSThe Lancet, 1974